Does AstraZeneca CEO Pascal Soriot really want to merge with Gilead? A Bloomberg story suggests he was interested — but it's hard to see why

Pascal Soriot has evidently been thinking big.

Completely out of left field, Bloomberg today posted a story early Sunday saying …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Does As­traZeneca CEO Pas­cal So­ri­ot re­al­ly want to merge with Gilead? A Bloomberg sto­ry sug­gests he was in­ter­est­ed — but it's hard to see why